This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive  Media Kit

Home   About   Scholarships   Meetings   Publications   Resources   April 08, 2014


Latest Application Notes

Download Waters latest application notes for Clinical Research.

 



Can a transplant drug help eliminate lingering HIV infections?
Los Angeles Times
Researchers studying the effects of immune suppressant drugs on transplant patients with HIV have made a surprising discovery: A drug intended to hobble the body's defense system may actually help destroy dormant reservoirs of the virus that causes AIDS. In a paper published in the American Journal of Transplantation, authors found that when a small group of transplant patients received the drug sirolimus, they experienced a two- to threefold drop in HIV levels, whereas patients who received other immunosuppressants did not.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Key chocolate ingredients could help prevent obesity, diabetes
American Chemical Society via ScienceDaily
The potential health benefits of dark chocolate keep piling up and scientists are now homing in on what ingredients in chocolate might help prevent obesity, as well as Type 2 diabetes. They found that one particular type of antioxidant in cocoa prevented laboratory mice from gaining excess weight and lowered their blood sugar levels.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Medical Laboratory Professionals Week — April 20-26
American Society for Clinical Laboratory Science
It is time to celebrate and educate others about what YOU do! Start planning your celebration now. Purchase official logo items, download the logo, and more at www.ascls.org/MLPW.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


SPONSORED CONTENT


April 17 webinar — Antimicrobial Susceptibility Testing Case Studies: Effective Resistance Detection and Reporting
American Society for Clinical Laboratory Science
Renowned expert Janet Hindler will present case studies to highlight the most clinically significant types of resistance encountered today, methods for accurate detection and options for results reporting. For more information and to register, go to www.ascls.org/webinars. ASCLS members register at a discount with code wsdc14.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Anticancer compounds show potential in schizophrenia
Medscape Medical News
Experimental p21-activated kinase inhibitors reversed schizophrenia-like behaviors and restored some lost brain function in a mouse model of schizophrenia. Researchers from the United States and Japan engineered mice to carry the mutant disrupted-in-schizophrenia 1 gene, which leads to synaptic deterioration akin to that seen in schizophrenia.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Novel CDK4/6 inhibitor shows strong promise in breast cancer
Medscape Medical News
A novel drug for breast cancer, palbociclib, has shown a significant clinical benefit in a subgroup of women with advanced breast cancer in a phase 2 trial, known as PALOMA-1. However, an expert at the meeting warned that the results come from a phase 2 trial, and that such results are not always confirmed in larger phase 3 trials.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Fatal virus in Ghana tests negative for Ebola
Reuters
Blood tests have shown that a 12-year-old girl in Ghana who died of viral fever with bleeding did not have Ebola, Health Minister Sherry Ayittey said. The girl was the first suspected case in Ghana of Ebola, which has killed more than 90 people in Guinea and Liberia. Another suspected case has been reported in Mali.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword VIRUS




Fighting cancer with lasers and nanoballoons that pop
HealthCanal
Chemotherapeutic drugs excel at fighting cancer, but they’re not so efficient at getting where they need to go. Now, researchers are developing a better delivery method by encapsulating the drugs in nanoballoons — which are tiny modified liposomes that, upon being struck by a red laser, pop open and deliver concentrated doses of medicine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Periodic puns: Chemistry jokes just in time for April Fools' Day (1) (')
New research shows promise in blood cancer treatment (By Rosemary Sparacio)
Researchers identify protein that helps control common viral infection (Johns Hopkins Children's Center via Infection Control Today)
WHO: Liberian health authorities confirm two cases of Ebola (Reuters)

Don't be left behind. Click here to see what else you missed.


Study: Mushrooms can fight cervical cancer
KHOU-TV
A recent study indicates that mushrooms can help fight cervical cancer. In the study, researchers treated cervical cancer cells with AHCC, which is a proprietary extract made from the thread-like part of the mushroom. Researchers were able to suggest that AHCC can eliminate HPB infections and may have a role in the prevention of HPV-related cancers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
JoinYour Peers

AMT is designed for and led by lab professionals like you! Enhance your professional growth by joining our team (ASCP certficants don’t need further testing).

www.americanmedtech.org
Advertise here!

To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


DNA test may gauge risk of prostate cancer's return
HealthDay News
A new DNA test can identify prostate cancer patients at high risk for a return of their cancer, researchers say. The test uses DNA from biopsy (tissue) samples taken before patients undergo surgery or radiation therapy for their cancer. The test is about 80 percent accurate in predicting which men have a high or low risk of their cancer returning within two years, according to the study.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Antibiotics in manure have a far-reaching impact on the abundance of human pathogenic bacteria in soils
Helmholtz Zentrum München via HealthCanal
Scientists of Helmholtz Zentrum München, in a joint study with researchers of Julius Kühn Institute in Braunschweig, have found that the repeated application of manure contaminated with antibiotics lastingly changes the composition of bacteria in the soil. In PLoS ONE, the researchers report that repeated application of the antibiotic sulfadiazine leads to a decrease in beneficial soil bacteria and at the same time an increase in bacteria that are harmful to humans.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
MOST POPULAR ARTICLE
TRENDING ARTICLE
Can a transplant drug help eliminate lingering HIV infections?
Los Angeles Times
Researchers studying the effects of immune suppressant drugs on transplant patients with HIV have made a surprising discovery: A drug intended to hobble the body's defense system may actually help destroy dormant reservoirs of the virus that causes AIDS.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
New research shows promise in blood cancer treatment
By Rosemary Sparacio
Blood cancers pose many challenges for healthcare professionals engaged in clinical research, patient care and treatment. Several new approaches published recently show promise for the future in this field of medicine.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
MIT researchers develop living material using E. coli
Nature World News
Researchers at Massachusetts Institute of Technology have created a material with the properties of both living and non living things using E. coli bacteria. Their study paves the way for futuristic self-assembling materials that could be used in solar cells and biosensors.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


Simple blood test to spot early lung cancer getting closer
NPR
At the Stanford School of Medicine, Dr. Maximilian Diehn spends some of his time as a radiation oncologist treating patients with cancer, and some of his time delving into the world of DNA. In particular, he's been working on ways to detect DNA that has been shed from a tumor and ends up in a patient's blood.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Diabetes tied to higher risk of pancreatic cancer in study
HealthDay News
People with diabetes have double the risk of pancreatic cancer compared to people who don't have diabetes, according to a new analysis of 88 previous studies. Diabetes has been considered a risk factor for pancreatic cancer, but what's not clear is which condition comes first. This new analysis suggests that at least for some people, pancreatic cancer might be responsible for diabetes.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news


This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free!

Recent issues

April 1, 2014
March 25, 2014
March 18, 2014
March 11, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063